Carrelizumab Plus Lenvatinib Combined With TACE
1 clinical trials · Condition
◉ Watch Carrelizumab Plus Lenvatinib Combined With TACE
| Record | Firm | Date |
|---|---|---|
| The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC (NCT05042336) | Sichuan University | 2021-09-01 |
Track Carrelizumab Plus Lenvatinib Combined With TACE automatically
Every clearance here is in the API, with alerts when new ones post.